“A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo controlled Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment of Adults with Major Depressive Disorder'
Open
- Protocol code: 382-201-00001
- EudraCT code: No aplica
- Research group: Psychiatry, Mental Health and Addictions
- Service: Psychiatry
- Principal investigator: Ramos Quiroga, José Antonio
- Pathology: Trastorns mentals i del comportament
- Phase: Fase III